Antibiotic use and risk of <i>Clostridioides difficile</i> infection in patients with inflammatory bowel disease
The use of clindamycin or metronidazole prescribed in an outpatient setting was associated with a statistically significant increased risk of CDI in patients with IBD. Although the association between clindamycin and CDI is a well-established and common finding, the association between metronidazole and CDI is unique in this study.
Authors
- Jaccallene Bomar
- Kristen M. Tecson (ORCID: https://orcid.org/0000-0002-6732-8698)
- Alexis Bejcek (ORCID: https://orcid.org/0000-0003-2191-2757)
- Anupama Ancha
- Ryan Beaver (ORCID: https://orcid.org/0000-0002-4166-9478)
- Megan A. Lewis (ORCID: https://orcid.org/0000-0002-1670-9298)
- Christopher Johnson (ORCID: https://orcid.org/0000-0001-6527-7594)
Institutions
- Baylor College of Medicine (US)
- Baylor Scott & White Medical Center - Temple (US)
- Baylor Scott & White Health (US)
Publication Details
- Journal
- Journal of Gastroenterology and Hepatology
- Published
- 2024-08-15
- DOI
- https://doi.org/10.1111/jgh.16720
- Citations
- 2
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.78